细胞研究(英文版)(Cell Research)

细胞研究(英文版)(Cell Research) 知网目次万方目次

  • CSCD
  • 科核
  • 高T1
基本信息
  • 主管单位:

    中国科学院

  • 主办单位:

    中国科学院分子细胞科学卓越创新中心、中国细胞生物学学会

  • 国际刊号:

    1001-0602;EISSN1748-7838

  • 国内刊号:

    31-1568

  • 学科分类:

    生物科学

  • 字数:

    4000-34000

  • 有无基金:

    /有基金 100.0%

  • 周期:

    CN外文-月刊

  • 特殊属性:

    第一批认定学术期刊

联系信息
  • 电话:

    021-54920953,54922841(官网电话)

  • 邮箱:

    cellres@sibcb.ac.cnleic@sibcb.ac.cn(官网邮箱)

  • 复合因子:

    3.358

  • 综合因子:

    2.35

  • 收录:

    知网目次,万方目次

  • 级别:

    CSCD,科核,高T1

期刊简介

《细胞研究(英文版)(Cell Research)》期刊已被查看:

更新频次

单位占比

一作占比

/有基金-100.0%

投稿指南

1、投稿方式:在线投稿。

2、刊内网址:(202402期)

http://www.nature.com/cr

http://www.cell-research.com/

3、投稿系统:

https://mts-cr.nature.com/cgi-bin/main.plex

4、出刊日期:月刊,一年出版12期。

2024年2月29日星期四

《细胞研究(英文版)》投稿指南

Guidelines-For Author

【官网信息】

Guidelines - For Author

Editorial policy

Submission to Cell Research implies that all authors have seen and approved the full manuscript. Corresponding authors of accepted papers will be required to sign a Licence to Publish form on behalf of all authors (see below). To avoid unnecessary delays in the review process, please consider the following policies carefully before submitting your manuscript.

Duplicate publication

Material submitted to the journal must be original and not published or submitted for publication elsewhere in any language. This policy applies to material submitted elsewhere while the contribution to Cell Research is under consideration. Authors submitting a manuscript should notify the editor(s) if part of their contribution has appeared or will appear elsewhere, or if any related material is under consideration or in press elsewhere.

If a submission contains a figure that is published elsewhere or that is copyrighted, the author must provide documentation that the previous publisher or copyright holder has given permission for the figure to be re-published. The editors consider all material in good faith, and assume that the journal has full permission to publish every part of the submitted material, including illustrations.

Conflicts of interest

In the interests of transparency and to help reviewers assess any potential bias, the journal asks authors of research articles to declare any competing commercial interests in relation to the submitted work. Referees are also asked to indicate any potential conflict they might have with reviewing a particular paper.

Electronic manipulation of images

Digital image enhancement is acceptable practice, although it can result in the presentation of unrepresentative data as well as in the loss of meaningful signals. During manipulation of images a positive relationship between the original data and the resulting electronic image must be maintained. If a figure has been subjected to significant electronic manipulation, the specific nature Guidelines for Authors of the enhancements must be noted in the figure legend or in the ‘Materials and methods’ section. The editors reserve the right to request original versions of figures from the authors of a paper under consideration.

Ethical considerations

Protocols for research projects involving human subjects or animals must have been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and must conform to the provisions of the Declaration of Helsinki (as revised in Edinburgh 2000). Any experiments involving animals must be demonstrated to be ethically acceptable and, where relevant, conform to national guidelines for animal usage in research.

Supplementary information for editors and reviewers

Any manuscripts under review or accepted for publication elsewhere should accompany the submission if they are relevant to its scientific assessment. Authors should also provide upon submission any kind of supplementary material that will aid the review process.

Format of Papers

Preparation of manuscripts

The manuscript should be double-spaced throughout using 15px Times New Roman/Arial. Number all pages, beginning from title page, and followed by abstract, introduction, results, discussion, materials and methods, acknowledgments, references, figure legends and figures/tables. Gene symbols should be italicized; protein products are not italicized. Non-standard abbreviations should be defined in brackets when first used in the text.

Title page: The title page should include: full title (a brief declarative statement of the major findings of the research), running title (no more than 60 characters including spaces), name of each author, affiliation, city with postal code and corresponding author’s contact information.

Abstract: The abstract should briefly (no more than 250 words) describe in complete sentences the scope of the investigation, the results obtained and the major conclusions. Abbreviations and reference citations should be avoided. 3-7 keywords should be given after the abstract.

Introduction: The introduction should give a brief background knowledge related to the research and should be as concise as possible.

Results: The results should clearly describe the experimental data in tables and figures.

Discussion: The discussion should focus on the interpretation and significance of the findings with concise objective comments.

Materials and Methods: The materials and methods should be described clearly and referenced in sufficient detail.

Acknowledgments: The acknowledgments should be brief and include financial supports along with the numbers of grants.

Gene nomenclature: Authors should use approved nomenclature for gene symbols, and use symbols rather than italicized full names (Ttn, not titin). Please consult the appropriate nomenclature databases for correct gene names and symbols. For proposed gene names that are not already approved, please submit the gene symbols to the appropriate nomenclature committees as soon as possible, as these must be deposited and approved before publication of an article.

References

The references should include only articles that are published or in press. The references are each numbered, ordered sequentially as they appear in the text. List all authors unless there are more than 6, in which case only the first 3 should be given, followed by “et al”.

Please use the following style for references:

Article in a Journal:

1 Zarubin T, Han JH. Activation and signaling of the p38 MAP kinase pathway. Cell Res 2005; 15:11-18. Chapter in a Book:

2 Hirsimaki P, Arstuka AU, Trump BF, Marzella L. Autophagocytosis. In: Trump BF, Arstuka AU, eds. Pathobiology of cell membranes. New York: Plenum Press, 1983:201-236.

A book:

3 Kryger M, Roth T, Dement W, eds. The Principles and Practice of Sleep Medicine. 2nd Edition. Philadelphia: WB Saunders, 1994.

Online Publication:

4 Jelinic P, Stehle JC, Shaw P. The testis-specific factor CTCFL cooperates with the protein methyltransferase PRMT7 in H19 imprinting control region methylation. PLoS Biol 2006; 4: e355.

DOI: 10.1371/journal.pbio.0040355

Figures

Figures and images should be labeled sequentially, numbered and cited in the text. Figures should be referred to specifically in the text of the paper but should not be embedded within the text. The use of three-dimensional histograms is strongly discouraged when the addition of the third dimension gives no extra information. If a table or figure has been published before, the authors must obtain written permission to reproduce the material in both print and electronic formats from the copyright owner and submit it with the manuscript. This follows for quotes, illustrations and other materials taken from previously published works not in the public domain.

#  First Name Last Name  Last Name

1  Mark  Otto Otto

2  Jacob Thornton    Thornton

3  Larry the Bird    the Bird

For submission, TIFF, PSD, AI, JPEG and EPS are recommended acceptable formats for the figures, which should be submitted separately. Use quality graphic programs such as Adobe PhotoShop, Adobe Illustrator, Corel Draw, or Freehand to create your figures. Standard figure sizes are 85mm (single column) and 175mm (double column). The full depth of the page is 210mm. Provide figures at about the size they are to be printed. Please use Helvetica or Arial fonts for the creation of figures.

Figure legends

Titles and legends to figures must be submitted for all figures. They should be brief and specific, and should appear on a separate manuscript page after the Reference section. Use scale markers in the image for electron micrographs, and indicate the type of stain used.

Tables

Tables should be labeled sequentially as Table 1, Table 2, etc. Each table should be typed on a separate page, numbered and titled, and cited in the text. Reference to table footnotes should be made by means of Arabic numerals. Tables should not duplicate the content of the text. They should consist of at least two columns; columns should always have headings. Authors should ensure that the data in the tables are consistent with those cited in the relevant places in the text, totals add up correctly, and percentages have been calculated correctly. Supply tables as Word, Excel or HTML files (one table per file). Include the table title and legend in the table file.

Supplementary information

All supplementary items, including figures, movies, tables, and data (extended Materials and Methods) should have a title or legend that briefly describe the data shown. Please cite each supplementary item in the main text at least once. It is posted on the journal's web site and linked to the article when the article is published, so the file sizes must be as small as possible to make it easy to download. Supplementary information is not subedited, so authors should ensure that it is supplied ready and correct for publication online.

File formats

File formats for manuscript files, figures and tables that are acceptable for our electronic manuscript submission process are given on the online forms. Please follow our artwork guidelines for submitting figures, and use a common word-processing package (such as Microsoft Word) for the text.

Letters to the Editor

Letters to the Editor provide rapid and concise report of a novel finding that is brief in nature but is of general interest to the field.

Specific format requirements for preparing a Letter:

There is no Abstract and no subsections on Introduction, Results or Discussion. Nevertheless, the beginning paragraphs should present concise but yet sufficient background information that would allow the readers to appreciate the rationale of the work, and put the study in a proper perspective.

The entire text should be no more than 1200 words.

Only one display item is allowed.

There should be no more than 10 references.

Generally, the information of Materials and Methods is not needed, but in the case when such information is unique and important to the study, it could be submitted as a supplement.

Submission of Papers

Manuscripts should be submitted via online submission at http://www.nature.com/cr or http://www.cell-research.com. However if you have problems with the online submission, please contact Cell Research editorial office at cellres@sibcb.ac.cn

Initial submission

1. Please make sure you have gathered all the required manuscript information listed as follows before starting submission. A cover letter stating that the manuscript has not been and will not be considered for publication elsewhere and giving a brief introduction to the novel findings of this work, along with three or more experts in the field as potential reviewers.

2. A declaration stating that all the authors agreed to submit the manuscript to Cell Research with the signature of the corresponding author. Licence to Submission should be signed and faxed to the editorial office of Cell Research. Fax: +86 (0) 21 5492 0952.

3. Electronic files including the text and the figures/tables.

Revised manuscript submission

Enclose a rebuttal letter to answer the comments of the reviewers and the editors when submitting a revised manuscript.

Getting help

If you need additional help, please contact the Cell Research editorial office (cellres@sibcb.ac.cn).

Licence to publish

The corresponding author must complete and sign the Licence to Publish form upon acceptance of the manuscript and return it to the editorial office. Failure to do so will result in delays to the publication of your paper.

Open access

Upon submission of an original research paper, authors can indicate within the manuscript tracking system whether they wish to pay an article processing charge for their article to be published open access. The article processing charge is £2,980/$4,390/€3,490 (plus VAT where applicable) and can be paid via credit card or by requesting an invoice be raised. By paying the article processing charge, authors are permitted to post the final, published pdf of their article on a website, institutional repository or other free public server immediately on publication.

Proofs and Offprints

Once the manuscript has been accepted, the corresponding author(s) will receive PDF proofs and is responsible for proofreading and checking the entire article. Authors should correct only typesetting errors, no major alteration of the text will be accepted. Page proofs must be returned within 48 hours to avoid delays in publication along with the offprint order if required. Later orders submitted after the journal is printed are subject to increased reprint prices.

Page Charges

Page charges are currently 500 RMB (US$80) per print page and 1500 RMB (US$200) per color page in the journal. These charges can be paid to Cell Research by Telegraph Transfer or Check by International Courier Companies.

(1) Telegraph transfer:

Item Title: Publication fee to Cell Research

Bank Name: Bank of China, Shanghai, Jianguo Rd.(W) Sub-Branch

Account Number: 458545000888

Account Name: CAS Center for Excellence in Molecular Cell Science

Address: Room 401, Building 31B, 319 Yueyang Road, Shanghai 200031, China.

(2) Remittance through Post Office

Account Name: Cell Research

Address: Room 401, Building 31B, 319 Yueyang Road, Shanghai 200031, China.

中国全科医学发文选摘

  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析

常见问题

  • 哪些期刊可以用来评职称?

    1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。

  • 你们的服务可以保证文章被发表吗?

    期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。

  • 请问发表一篇期刊的费用是多少?

    期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。

  • 如果发表不成功可以退款吗?

    如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。

  • 请问文章发表需要多长时间?

    不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。

  • 期刊发表能加急见刊吗?

    为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。